C. difficile: the most common healthcare-associated infection

Clostridioides difficile can easily spread through healthcare settings, wreaking additional misery on those already ill. Learn more about this common HAI.
Person holding a BioFire® syndromic pouch.

Economic Value of the BioFire GI Panel

/
The BioFire FilmArray GI Panel can lead to meaningful cost and resource savings compared to traditional testing methods for gastrointestinal infections.

Cost Savings with Syndromic Meningitis/Encephalitis Testing from BioFire

Investing in syndromic meningitis/encephalitis testing from BioFire can provide many benefits over time, including significant cost savings.

The Benefit of Point-of-Care Diagnostic Testing

Point-of-care diagnostic testing has many benefits including being more convenient for patients. Learn about BioFire's point-of-care testing solutions.

World Meningitis Day 2021

April 24, is World Meningitis Day—24 hours devoted to raising global awareness about a dangerous infectious disease that can affect anyone.

What is Sepsis?

/
Sepsis is the result of a body’s extreme response to an infection & at least 1.7 million adults in the US develop sepsis every year. Learn more about sepsis.
For Labs

All About Fungal Infections

While fungi don't usually pose a threat to human health, several fungal infections can lead to sepsis or meningitis. Learn how syndromic testing can help.

Sepsis and Antimicrobial Resistance: Finding Balance

/
Sepsis & concerns about AMR can seemingly pull prescribers in opposite directions, learn why this study suggests they are two sides of the same coin.

Why ASPs Should be Included in Healthcare Emergency Preparedness Efforts

/
The COVID-19 pandemic illustrated why antimicrobial stewardship programs should be incorporated into a healthcare organization’s disaster preparedness plans.
Lab technician loading a syndromic testing pouch into the BioFire® Torch System.

Best Uses of BioFire SARS-CoV-2 Syndromic Testing Based on Updated WHO Guidelines

/
Here's what users of BioFire’s SARS-CoV-2 syndromic testing solutions should know in response to the WHO's updated testing guidelines.